Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001641172-25-009072
Filing Date
2025-05-07
Accepted
2025-05-07 17:15:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5032
  Complete submission text file 0001641172-25-009072.txt   6666
Mailing Address 25 N MARKET STREET #205 JACKSONVILLE FL 32202
Business Address
Friedman Lance (Filed by) CIK: 0001470622 (see all company filings)

Type: SCHEDULE 13G/A

Mailing Address 194 CANDELARO DRIVE, #233 HUMACAO PR 00791
Business Address 194 CANDELARO DRIVE, #233 HUMACAO PR 00791 561-704-8527
Aspire Biopharma Holdings, Inc. (Subject) CIK: 0001847345 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-93583 | Film No.: 25922729
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)